Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q1 EPS of ($3.15), $0.09 better than the analyst estimate of ($3.24).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.